421
Views
13
CrossRef citations to date
0
Altmetric
Research Report

The impact of South Korea’s new drug-pricing policy on market competition among off-patent drugs

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Simran Khanijo, Ashish Kumar Kakkar, Rohit Kumar, Amol Narayan Patil, Gomata Bhusal, Gopal Vishwas & Geetika Arora. (2020) Impact of pharmaceutical price controls on the cost of cardiovascular drugs: does essentiality matter?. Expert Review of Clinical Pharmacology 13:7, pages 797-806.
Read now
Junjie Liu, Liming Wang, Chenxi Liu & Xinping Zhang. (2017) Impact of price deregulation policy on the affordability of essential medicines for women’s health: a panel data analysis. Expert Review of Pharmacoeconomics & Outcomes Research 17:6, pages 625-631.
Read now

Articles from other publishers (11)

Dong‐Sook Kim, Jihye Shin & Jusun Chung. (2021) Analysis of the Korean generic medicine market: Factors affecting the market share of generic medicines. Clinical and Translational Science 15:2, pages 433-441.
Crossref
Mingyue Zhao, Peng Nie & Jing Wu. (2021) Heterogeneity in Price Elasticity of Medicine Demand in China: Moderate Effect From Economic Incentive and Quality Difference. Frontiers in Pharmacology 12.
Crossref
Brian Godman, Joseph Fadare, Hye-Young Kwon, Carolina Zampirolli Dias, Amanj Kurdi, Isabella Piassi Dias Godói, Dan Kibuule, Iris Hoxha, Sylvia Opanga, Zikria Saleem, Tomasz Bochenek, Vanda Marković-Peković, Ileana Mardare, Aubrey C Kalungia, Stephen Campbell, Eleonora Allocati, Alice Pisana, Antony P Martin & Johanna C Meyer. (2021) Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research 10:12, pages 1019-1052.
Crossref
Mingyue Zhao, Lingyi Zhang, Zhitong Feng & Yu Fang. (2021) Physicians’ Knowledge, Attitude and Practice of Generic Substitution in China: A Cross-Sectional Online Survey. International Journal of Environmental Research and Public Health 18:15, pages 7749.
Crossref
HyeYeong Lee, Dahye Park & Dong-Sook Kim. (2021) Determinants of Growth in Prescription Drug Spending Using 2010–2019 Health Insurance Claims Data. Frontiers in Pharmacology 12.
Crossref
Hye-Jae Lee, Euna Han & Hyero Kim. (2020) Comparison of Utilization Trends between Biosimilars and Generics: Lessons from the Nationwide Claims Data in South Korea. Applied Health Economics and Health Policy 18:4, pages 557-566.
Crossref
Syed Shahzad Hasan, Chia Siang Kow, Dalia Dawoud, Omneya Mohamed, Darrin Baines & Zaheer-Ud-Din Babar. (2019) Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea. Value in Health Regional Issues 18, pages 18-23.
Crossref
Hye-Young Kwon, Seungjin Bae, Sang-eun Choi, Sylvia Park, Eui-Kyung Lee, Sungmin Park & Jinhyun Kim. (2019) Easy cuts, easy rebound: Drug expenditures with massive price cuts in Korea. Health Policy 123:4, pages 388-392.
Crossref
Peter Schneider & Sabine Vogler. 2019. Medicine Price Surveys, Analyses and Comparisons. Medicine Price Surveys, Analyses and Comparisons 113 164 .
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Steven Simoens, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso GuerraJr.Jr., Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Zinhle Matsebula, Stephen Campbell & Alan Haycox. (2018) Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. Frontiers in Public Health 6.
Crossref
Hye-Young Kwon & Brian Godman. (2017) Drug Pricing in South Korea. Applied Health Economics and Health Policy 15:4, pages 447-453.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.